Symbol Name ID |
S100a16
S100 calcium binding protein A16 MGI:1915110 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
S100a16em1(IMPC)J/S100a16+ C57BL/6NJ-S100a16em1(IMPC)J/Mmjax |
decreased circulating calcium level | J:211773 |
S100a16em1(IMPC)J/S100a16em1(IMPC)J C57BL/6NJ-S100a16em1(IMPC)J/Mmjax |
abnormal embryo size | J:211773 |
abnormal placenta morphology | J:211773 | |
preweaning lethality, incomplete penetrance | J:211773 | |
S100a16em1.1Gpt/S100a16+ involves: C57BL/6JGpt * FVB/N |
decreased circulating alanine transaminase level | J:330793 |
decreased circulating aspartate transaminase level | J:330793 | |
decreased susceptibility to injury | J:330793 | |
liver fibrosis | J:330793 | |
Tg(CAG-S100a16)#Gpt/0 C57BL/6J-Tg(CAG-S100a16)#Gpt |
normal homeostasis/metabolism phenotype | J:330793 |
liver fibrosis | J:330793 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/17/2024 MGI 6.24 |
![]() |
|